Regeneron Raised to $851 By Morgan Stanley; Zscaler Boosted to $210 By RBC Capital | Price Target Changes-To The Moon - Tiger Brokers Online Investing Community

97
6
Favorite

Regeneron Raised to $851 By Morgan Stanley; Zscaler Boosted to $210 By RBC Capital | Price Target Changes

Benzinga2022-09-09

Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. from $625 to $851. Morgan Stanley analyst Matthew Harrison also upgraded the stock from Equal-Weight to Overweight. Regeneron ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（6）

lcw5257
·2022-09-11
Sure to buy
Reply
Like
Report
Bspn
·2022-09-09
Ok
Reply
Like
Report
来人
·2022-09-09
Ok
Reply
1
Report
GggSlimeR
·2022-09-09
Hi Thanks & Do not like my comment
Reply
2
Report
Kian009
·2022-09-09
Nice
Reply
Like
Report
Footixx
·2022-09-09
👍
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1131692594?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-09-09 20:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131692594","market":"us","top_or_hot":-1,"title":"Regeneron Raised to $851 By Morgan Stanley; Zscaler Boosted to $210 By RBC Capital | Price Target Changes","media":"Benzinga","content":"<div>\n<p>Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. from $625 to $851. Morgan Stanley analyst Matthew Harrison also upgraded the stock from Equal-Weight to Overweight. Regeneron ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/09/28808993/regeneron-pharmaceuticals-to-851-here-are-5-other-price-target-changes-for-friday\">Source Link</a>\n\n</div>\n","source":"lsy1606299360108","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron Raised to $851 By Morgan Stanley; Zscaler Boosted to $210 By RBC Capital | Price Target Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron Raised to $851 By Morgan Stanley; Zscaler Boosted to $210 By RBC Capital | Price Target Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-09 20:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/09/28808993/regeneron-pharmaceuticals-to-851-here-are-5-other-price-target-changes-for-friday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. from $625 to $851. Morgan Stanley analyst Matthew Harrison also upgraded the stock from Equal-Weight to Overweight. Regeneron ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/09/28808993/regeneron-pharmaceuticals-to-851-here-are-5-other-price-target-changes-for-friday\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元制药公司","start_time":0,"source_url":"https://www.benzinga.com/news/22/09/28808993/regeneron-pharmaceuticals-to-851-here-are-5-other-price-target-changes-for-friday","article_id":"1131692594","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131692594","pubTimestamp":1662726340,"sourceInfo":{"source_id":"lsy1606299360108","name":"Benzinga"},"weMediaInfo":null,"summary":"Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. from $625 to $851. Morgan ","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司","ALGN":"艾利科技","NAVI":"Navient Corp","ZS":"Zscaler Inc.","LOVE":"Lovesac Co.","AXL":"美国车桥"},"translate_title":"摩根士丹利将雷根龙融资至851美元；RBC资本价格目标变化推动Zscaler升至210美元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALGN":0.9,"AXL":0.9,"LOVE":0.9,"NAVI":0.9,"REGN":0.9,"ZS":0.9},"content_text":"Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. from $625 to $851. Morgan Stanley analyst Matthew Harrison also upgraded the stock from Equal-Weight to Overweight. Regeneron Pharmaceuticals shares rose 0.9% to $714.99 in pre-market trading.RBC Capital boosted Zscaler, Inc. price target from $200 to $210. RBC Capital analyst Matthew Hedberg maintained the stock with an Outperform rating. Zscaler shares rose 13.5% to $175.11 in pre-market trading.B of A Securities cut American Axle & Manufacturing Holdings, Inc. price target from $16 to $13. B of A Securities analyst John Murphy also downgraded the stock from Buy to Neutral. American Axle shares fell 2.1% to $9.66 in pre-market trading.Oppenheimer cut The Lovesac Company price target from $95 to $60. Stifel analyst Parker Lane maintained a Buy rating on the stock. Lovesac shares rose 1.8% to $26.65 in pre-market trading.Barclays lowered Navient Corporation price target from $19 to $13. Barclays analyst Mark Devries also downgraded the stock from Overweight to Equal-Weight. Navient fell 0.1% to $15.00 in pre-market trading.Piper Sandler cut Align Technology, Inc. price target from $370 to $340. Piper Sandler analyst Jason Bednar maintained an Overweight rating on the stock. Align Technology shares rose 0.7% to $259.00 in pre-market trading.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9932969335,"gmtCreate":1662864049327,"gmtModify":1676537153368,"author":{"id":"3576290774854482","authorId":"3576290774854482","name":"lcw5257","avatar":"https://static.tigerbbs.com/a9673efde3b5f524d0c3fa6d098ee6eb","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3576290774854482","idStr":"3576290774854482"},"htmlText":"Sure&nbsp; to buy&nbsp;","listText":"Sure&nbsp; to buy&nbsp;","text":"Sure to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9932969335","repostId":1131692594,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9936142367,"gmtCreate":1662733555559,"gmtModify":1676537129588,"author":{"id":"3582502134655895","authorId":"3582502134655895","name":"Bspn","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3582502134655895","idStr":"3582502134655895"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9936142367","repostId":1131692594,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9936181425,"gmtCreate":1662727585268,"gmtModify":1676537127921,"author":{"id":"3575544575320394","authorId":"3575544575320394","name":"来人","avatar":"https://static.tigerbbs.com/0af89587decbb8a1d3e1596adc29cb98","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3575544575320394","idStr":"3575544575320394"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9936181425","repostId":1131692594,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9936181219,"gmtCreate":1662727569931,"gmtModify":1676537127913,"author":{"id":"4093058604760480","authorId":"4093058604760480","name":"GggSlimeR","avatar":"https://community-static.tradeup.com/news/4b805c8472adab6d9418f36452434a56","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":1,"authorIdStr":"4093058604760480","idStr":"4093058604760480"},"htmlText":"Hi Thanks &amp; Do not like my comment&nbsp;","listText":"Hi Thanks &amp; Do not like my comment&nbsp;","text":"Hi Thanks & Do not like my comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9936181219","repostId":1131692594,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9936117871,"gmtCreate":1662726651393,"gmtModify":1676537127795,"author":{"id":"4094002792025060","authorId":"4094002792025060","name":"Kian009","avatar":"https://static.tigerbbs.com/e1c6d48cecc37bed8feda64b2140253b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4094002792025060","idStr":"4094002792025060"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9936117871","repostId":1131692594,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9936114167,"gmtCreate":1662726253459,"gmtModify":1676537127764,"author":{"id":"3572228950547010","authorId":"3572228950547010","name":"Footixx","avatar":"https://static.tigerbbs.com/286a694c51da40f13325f2f7cd6b8851","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3572228950547010","idStr":"3572228950547010"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9936114167","repostId":1131692594,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":97,"commentSize":6,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}